Work

CLO25-053: Real-World Evidence of Survival in Patients With Metastatic NSCLC Treated With First-Line Immune Checkpoint Inhibitors Beyond Progression

Year: 2025

Type: article

Source: Journal of the National Comprehensive Cancer Network

DOI: 10.6004/jnccn.2024.7160

Authors: Natalie Johns, Alexander Rudich, Songzhu Zhao, Kenneth Chian, Po-Lan Su, Adam Khorasanchi, Jinesh Gheeya, Daniel Spakowicz, Lai Wei, Logan Roof, Asrar Alahmadi, Regan Memmott, Jacob Kaufman, Carolyn Presley, Kai He, Peter Shields, Christian Rolfo, David Carbone, Dwight Owen, Mingjia Li

Institutions: The Ohio State University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

Award: Training Hematology and Oncology Fellows in Clinical Research

OpenAlex ID: W4408939908

FWCI:

Cites:

Cited by:

Related to: 10